MedTrace Logo

A Study of Absorption, Metabolism, Excretion of [14C]-NS-580 in Healthy Male Subjects

NCT06670898 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 8

Last updated 2024-11-01

No results posted yet for this study

Summary

The purpose of this study was to determine the absorption, metabolism, and excretion of radioactivity and to characterize and determine, where possible, the metabolites present in plasma, urine, and faeces in healthy male subjects following a single oral administration of \[14C\]-NS-580.

Conditions

  • Healthy

Interventions

DRUG

[14C] NS-580

Oral suspension

Sponsors & Collaborators

  • Nippon Shinyaku Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
35 Years
Max Age
60 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-08
Primary Completion
2024-01-18
Completion
2024-01-18

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06670898 on ClinicalTrials.gov